Literature DB >> 30232657

Do Limitations in the Design of PARADIGM-HF Justify the Slow Real World Uptake of Sacubitril/Valsartan (Entresto)?

Rosa Ahn1, Vinay Prasad2,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30232657     DOI： 10.1007/s10557-018-6830-x

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  2 in total

1.  Efficacy and safety of sacubitril/valsartan in the treatment of heart failure: protocol for a systematic review incorporating unpublished clinical study reports.

Authors:  David Byrne; Tom Fahey; Frank Moriarty
Journal:  HRB Open Res       Date:  2021-04-01

Review 2.  Recently Approved and Under Investigation Drugs for Treating Patients with Heart Failure.

Authors:  Yaniel Castro-Torres; Richard E Katholi
Journal:  Curr Cardiol Rev       Date:  2020
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.